User profiles for Myriam Remmelink
Myriam RemmelinkCUB ULB Hopital Erasme Verified email at erasme.ulb.ac.be Cited by 5321 |
The Banff 2007 working classification of skin‐containing composite tissue allograft pathology
…, P Ruiz, L Landin, M Remmelink… - American Journal of …, 2008 - Wiley Online Library
Composite tissue allotransplantation (CTA) is a recently introduced option for limb replacement
and reconstruction of tissue defects. As with other allografts, CTA can undergo immune‐…
and reconstruction of tissue defects. As with other allografts, CTA can undergo immune‐…
[HTML][HTML] Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
M Remmelink, R De Mendonça, N D'Haene… - Critical care, 2020 - Springer
Background Post-mortem studies can provide important information for understanding new
diseases and small autopsy case series have already reported different findings in COVID-19 …
diseases and small autopsy case series have already reported different findings in COVID-19 …
[HTML][HTML] Methods of measurement for tumor mutational burden in tumor tissue
…, S Rorive, M Remmelink… - … lung cancer research, 2018 - ncbi.nlm.nih.gov
Immunotherapies based on immune checkpoint inhibitors are emerging as an innovative
treatment for different types of advanced cancers. While the utility of immune checkpoint …
treatment for different types of advanced cancers. While the utility of immune checkpoint …
Cancer biomarker sensing using packaged plasmonic optical fiber gratings: Towards in vivo diagnosis
…, S Chevineau, P Lambert, M Remmelink… - Biosensors and …, 2017 - Elsevier
This work presents the development of an innovative plasmonic optical fiber (OF)
immunosensor for the detection of cytokeratin 17 (CK17), a biomarker of interest for lung cancer …
immunosensor for the detection of cytokeratin 17 (CK17), a biomarker of interest for lung cancer …
Imaging infection with 18F-FDG–labeled leukocyte PET/CT: initial experience in 21 patients
…, D Blocklet, B Stallenberg, M Remmelink… - Journal of Nuclear …, 2006 - Soc Nuclear Med
The aim of this study was to assess the feasibility and the potential role of PET/CT with 18 F-FDG–labeled
autologous leukocytes in the diagnosis and localization of infectious lesions. …
autologous leukocytes in the diagnosis and localization of infectious lesions. …
Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension
…, F Kerbaul, S Motte, R Van Beneden, M Remmelink… - Circulation, 2003 - Am Heart Assoc
Background— The dual endothelin-receptor antagonist bosentan has been reported to
improve pulmonary arterial hypertension, but the role of endothelins in the pathogenesis of the …
improve pulmonary arterial hypertension, but the role of endothelins in the pathogenesis of the …
Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma
…, C Decaestecker, M Remmelink… - The …, 2012 - Wiley Online Library
Objectives/Hypothesis: The prevalence of human papillomavirus (HPV) in a clinical series
of 162 patients with oral squamous cell carcinoma (OSCC) was studied. Furthermore, we …
of 162 patients with oral squamous cell carcinoma (OSCC) was studied. Furthermore, we …
[HTML][HTML] COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review
…, M Lammens, M Osborn, M Remmelink… - Clinical Microbiology …, 2022 - Elsevier
Background Many postmortem studies address the cardiovascular effects of COVID-19 and
provide valuable information, but are limited by their small sample size. Objectives The aim …
provide valuable information, but are limited by their small sample size. Objectives The aim …
ARDS: a clinicopathological confrontation
Q De Hemptinne, M Remmelink, S Brimioulle, I Salmon… - Chest, 2009 - Elsevier
Background The heterogeneity of populations meeting criteria for ARDS may explain in part
why no specific treatment has yet been shown to decrease mortality. To define the …
why no specific treatment has yet been shown to decrease mortality. To define the …
[HTML][HTML] Clinical validation of targeted next generation sequencing for colon and lung cancers
…, H El Housni, B Dessars, P Heimann, M Remmelink… - PLoS …, 2015 - journals.plos.org
Objective Recently, Next Generation Sequencing (NGS) has begun to supplant other
technologies for gene mutation testing that is now required for targeted therapies. However, …
technologies for gene mutation testing that is now required for targeted therapies. However, …